Skip to main content

Table 1 Clinical and Biological Characteristic of CHD Patients with Diabetes and CHD Patients without Diabetes

From: High-density lipoprotein subclass and particle size in coronary heart disease patients with or without diabetes

  CHD Patients with Diabetes (n = 115) CHD Patients without Diabetes (n = 97)
Age(yr) 67.1 ± 9.7 63.7 ± 8.3
Female/Male 45/70 53/44
SBP(mmHg) 135.2 ± 20.6 130.8 ± 17.7
DBP(mmHg) 77.6 ± 8.4 75.7 ± 7.5
BMI(kg/m 2 ) 25.0 ± 2.6 24.3 ± 2.1
Waist (cm) 92.4 ± 8.6 88.1 ± 7.8
Hip (cm) 94.2 ± 6.4 93.1 ± 5.7
WHR 0.98 ± 0.1 0.94 ± 0.1
Gensini Score 53.7 ± 9.2 22.9 ± 6.3
FPG(mmol/L) 9.0 ± 1.2 5.2 ± 0.6
TG(mmol/L) 2.2 ± 0.5 1.8 ± 0.6*
TC(mmol/L) 4.4 ± 1.1 3.9 ± 1.0*
LDL-C(mmol/L) 3.4 ± 1.0 2.7 ± 0.7
HDL-C(mmol/L) 1.0 ± 0.2 1.3 ± 0.2
ApoA-I(g/L) 1.1 ± 0.2 1.3 ± 0.3*
ApoB-100(g/L) 0.8 ± 0.2 0.6 ± 0.2*
ApoB-100/A-I 0.7 ± 0.2 0.5 ± 0.1*
Preβ 1 -HDL(mg/L) 92.0 ± 9.5 83.0 ± 7.0
HDL 3c (mg/L) 83.9 ± 7.4 78.5 ± 6.9
HDL 3b (mg/L) 170.2 ± 20.9 142.5 ± 18.2*
HDL 3a (mg/L) 310.5 ± 44.7 272.5 ± 38.1*
HDL 2a (mg/L) 190.5 ± 25.8 285.9 ± 42.2
HDL 2b+Preβ2-HDL (mg/L) 311.9 ± 52.2 389.3 ± 69.5
  1. CHD, coronary heart disease; BMI, body mass index; FPG, fasting plasma glucose; TG, triglyceride; TC, total cholesterol; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; ApoA-I, apolipoproteinA-I; ApoB-100, apolipoprotein B-100.
  2. Data are presented as Mean ± S.D.
  3. *P < 0.05, P < 0.01, P < 0.001 vs CHD with diabetic patients.